Clinical Trial Update: Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study of belotecan in combination with cisplatin for previously untreated, extensive-stage small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Belotecan (Belotecan)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Yonsei University | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED